ICD-10 Code B02.21 | Postherpetic geniculate ganglionitis Symptoms, Diagnosis, Billing

Postherpetic geniculate ganglionitis is a complication of herpes zoster (shingles) characterized by inflammation of the geniculate ganglion, leading to severe pain and neurological symptoms. This condition is clinically significant as it can result in persistent pain and disability. The ICD-10 Code B02.21 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring appropriate management and resource allocation.

What is ICD-10 Code B02.21 for Postherpetic geniculate ganglionitis?

ICD-10 Code B02.21 represents Postherpetic geniculate ganglionitis, a painful condition resulting from the reactivation of the varicella-zoster virus. This code should be used in clinical documentation and billing when a patient presents with symptoms related to this specific complication of herpes zoster, ensuring proper identification and management of the condition.

ICD-10 Code B02.21 – Clinical Definition and Explanation of Postherpetic geniculate ganglionitis

Postherpetic geniculate ganglionitis occurs following herpes zoster infection, where the virus reactivates and causes inflammation of the geniculate ganglion. This condition requires medical attention due to the potential for chronic pain and neurological deficits. Early diagnosis and treatment are crucial for improving patient outcomes.

Key Clinical Features:

• Severe unilateral facial pain, often described as burning or stabbing.
• Possible facial weakness or paralysis due to nerve involvement.
• Sensory abnormalities, including hyperesthesia or allodynia in the affected area.
• History of herpes zoster infection in the preceding months.

ICD-10 Code B02.21 for Postherpetic geniculate ganglionitis – SOAP Notes & Clinical Use

In SOAP notes, ICD-10 Code B02.21 is utilized to document the diagnosis of Postherpetic geniculate ganglionitis, aiding in the assessment of symptoms, treatment plans, and follow-up care. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code B02.21 for Postherpetic geniculate ganglionitis Mean in SOAP Notes?

ICD-10 Code B02.21 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Postherpetic geniculate ganglionitis. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code B02.21 – Postherpetic geniculate ganglionitis

Postherpetic geniculate ganglionitis requires prompt treatment to alleviate symptoms and prevent complications. Hospitalization may be necessary for severe cases.

Antibiotic Therapy:

• Antiviral therapy (e.g., Acyclovir) is recommended for acute management.
• Consider alternative antivirals (e.g., Valacyclovir) if necessary.
• Duration typically ranges from 7 to 10 days.

Supportive Care:

• Pain management with analgesics or neuropathic pain medications.
• Physical therapy to improve function and reduce pain.
• Psychological support for coping with chronic pain.

Infection Control:

• Standard precautions to prevent the spread of varicella-zoster virus.
• Isolation of infected patients during acute outbreaks.

How to Document Symptoms of Postherpetic geniculate ganglionitis (ICD-10 B02.21) in SOAP Notes

Subjective:

• Patient reports severe, burning pain on one side of the face.
• History of shingles infection two months prior.
• Complaints of facial weakness and sensitivity to touch.
• Symptoms worsening at night, affecting sleep.

Objective:

• Facial examination reveals unilateral weakness.
• Increased sensitivity noted on the affected side.
• Vital signs stable; no fever present.
• Neurological examination shows diminished reflexes on the affected side.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Postherpetic geniculate ganglionitis (ICD-10 Code B02.21)

Assessment:

• Diagnosis: Postherpetic geniculate ganglionitis, moderate severity.
• ICD-10 Code: B02.21.
• Triggers: Recent herpes zoster infection.
• Contributing factors: Age and immune status.

Plan:

• Initiate antiviral therapy (Acyclovir) for 7 days.
• Prescribe analgesics for pain management.
• Refer to physical therapy for rehabilitation.
• Schedule follow-up in 2 weeks to assess progress.

Treatment & Plan Section for ICD-10 Code B02.21 – Postherpetic geniculate ganglionitis

• First-line treatment includes antiviral medications to reduce viral load.
• Consider adjunctive therapies such as gabapentin for neuropathic pain.
• Monitor patient response to treatment and adjust as necessary.
• Educate patient on the importance of follow-up care and symptom management.

Using ICD-10 Code B02.21 for Postherpetic geniculate ganglionitis in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and history in Subjective (S) and Objective (O) sections.
• Use ICD-10 Code B02.21 to support the medical necessity of treatments provided.
• Align treatment plans with clinical guidelines to justify billing.
• Include relevant CPT codes that correspond to the services rendered.

Related ICD-10 Codes Often Used with Postherpetic geniculate ganglionitis

• B02.22 – Postherpetic neuralgia, localized
• B02.29 – Other postherpetic neuralgia

ICD-10 Code B02.21 in Medical Billing and Insurance for Postherpetic geniculate ganglionitis

ICD-10 Code B02.21 is crucial for billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document all relevant patient history and clinical findings to support the diagnosis.
• Use this code in conjunction with other relevant codes for comprehensive billing.
• Ensure that treatment plans are clearly outlined in the medical record.

Common CPT Pairings: